April 18, 2014 3:58 PM ET

Biotechnology

Company Overview of ScarX Therapeutics

Company Overview

ScarX Therapeutics, a pre-clinical stage biotechnology company, engages in the development of a therapeutic as the patient-administered prescription medication for the prophylaxis of dermal scarring in post-surgical wound closures. It develops MI-001 as an anti-scarring agent. The company is based in Toronto, Canada.

Toronto, ON 

Canada

Key Executives for ScarX Therapeutics

Chief Executive Officer
Chief Development Officer
Chief Scientific Officer
Compensation as of Fiscal Year 2013.

ScarX Therapeutics Key Developments

ScarX Therapeutics Presents at 12th Annual BIO Investor Forum, Oct-08-2013 10:00 AM

ScarX Therapeutics Presents at 12th Annual BIO Investor Forum, Oct-08-2013 10:00 AM. Venue: The Palace Hotel, 2 New Montgomery Street, San Francisco, CA 94105, United States.

Similar Private Companies By Industry

Company Name Region
Receptor Therapeutics Inc. Americas
CanPro Ingredients Ltd. Americas
CIHC Biodev Inc. Americas
Bioxalis Medica inc. Americas
Milestone Pharmaceuticals Inc. Americas

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Rush University United States
Greater Houston Partnership United States

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ScarX Therapeutics, please visit www.scarxtherapeutics.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.